le débat nfp-rn sur lci avec pierre jouvet et laurent jacobelli
Published 3 months ago • 78K plays • Length 25:59Download video MP4
Download video MP3
Similar videos
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
2:38
nacfc 2021 | delivery challenges animation
-
20:44
"nous demandons une dissolution le plus vite possible" : laurent jacobelli invité de lci
-
1:07:35
maternal immune dysregulation and neurodevelopmental disorders
-
3:20
matching-adjusted indirect comparisons of acalabrutinib vs ibrutinib in treatment-naïve cll
-
39:46
602 dr lilie lin15 35 16 20 making advances in the treatment of gynecologic cancers
-
2:19
model-based regulation: lending in times of covid
-
2:33
meet linda van le, md: gynecologic oncology program
-
6:48
ntlf 2024: in conversation with thulci aluwihare, deputy managing director, chec port city colombo
-
4:48
j.s. bach: hunting cantata, bwv 208 - no. 9. sheep may safely graze (transc. duck for 4...
-
5:51
berkeley scientists study baby brainpower
-
1:53
network-based planning liberates creation, connection, collaboration
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
1:49:02
l&cp symposium 2016 | consumer credit & the consumer financial protection bureau
-
4:10
ibrutinib and venetoclax continue to provide benefits for patients with chronic cll and sll
-
1:37
dr. levis on the background and future of quizartinib for aml
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
4:42
ucl research | regulatory networks within the immune system | mirna-142
-
1:38
【education】what is lbe? iii-3.design your own lbe
-
1:04
dr. levis on quizartinib in aml patients without the flt3-itd mutation
-
1:08:16
clb symposium | legal and regulatory
-
11:27
anna david (prenatal cell and gene therapy, ifwh) ucltedx